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Abstract
Background
The outbreak of Zika virus (ZIKV) in the Americas has transformed a previously obscure
mosquito-transmitted arbovirus of the Flaviviridae family into a major public health concern.
Little is currently known about the evolution and biology of ZIKV and the factors that contrib-
ute to the associated pathogenesis. Determining genomic sequences of clinical viral iso-
lates and characterization of elements within these are an important prerequisite to
advance our understanding of viral replicative processes and virus-host interactions.
Methodology/Principal findings
We obtained a ZIKV isolate from a patient who presented with classical ZIKV-associated
symptoms, and used high throughput sequencing and other molecular biology approaches
to determine its full genome sequence, including non-coding regions. Genome regions
were characterized and compared to the sequences of other isolates where available. Fur-
thermore, we identified a subgenomic flavivirus RNA (sfRNA) in ZIKV-infected cells that
has antagonist activity against RIG-I induced type I interferon induction, with a lesser effect
on MDA-5 mediated action.
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Conclusions/Significance
The full-length genome sequence including non-coding regions of a South American ZIKV
isolate from a patient with classical symptoms will support efforts to develop genetic tools
for this virus. Detection of sfRNA that counteracts interferon responses is likely to be impor-
tant for further understanding of pathogenesis and virus-host interactions.
Author Summary
The current ZIKV outbreak is a major public health concern in the Americas. To further
understand the virus, and to develop tools and potentially vaccines, more information on
the virus strains circulating in the Americas is required. Here we describe the full-length
sequence of a ZIKV isolate from a patient with classical symptoms, including the complete
non-coding regions which are missing frommany currently available sequences, and put
these in context. Moreover, we also demonstrate the production of an RNA molecule
derived from the 3’ untranslated region that counteracts interferon responses and may
therefore be important for understanding the pathogenesis of ZIKV infection.
Introduction
Zika virus (ZIKV) is a mosquito-transmitted arbovirus in the Flavivirus genus, Flaviviridae
family. This previously obscure virus has recently caused large scale outbreaks in French Poly-
nesia in 2013 [1, 2], New Caledonia [3], the Cook Islands [4] and Easter Island [5] in 2014 and
the Americas in May 2015, beginning in Brazil [6, 7]. These outbreaks have been characterized
by an increased prevalence of neurological syndromes, such as Guillain-Barré syndrome and
microcephaly [8–13], which has heightened public concern. As of April 2016 theWorld Health
Organization (WHO) announced that 60 countries had reported autochthonous transmission
in the escalating epidemic originating in Bahia, Brazil in 2015 that has so far resulted in over
1.5 million suspected cases [14]. This unprecedented spread combined with the associated neu-
rological conditions resulted inWHO declaring a global public health emergency in February
2016.
Brazil has the greatest burden of dengue virus (DENV), a related flavivirus, in the world and
the ongoing ZIKV epidemic is occurring in areas where such mosquito-borne arboviruses are a
major public health problem. This is due to widespread arbovirus vectors such as Aedes aegypti
and Ae. albopictus which are important vectors of DENV and chikungunya virus (CHIKV,
Togaviridae), as well as ZIKV [15–19]. Clinicalmanifestations of ZIKV are similar to symp-
toms of DENV or CHIKV infectionsmakingmisdiagnosis common [3, 20]. Only 20% of ZIKV
infections are thought to progress to clinical symptoms, which present as an acute, self-limiting
illness comprising fever, myalgia, headache, polyarthralgia, nonpurulent conjunctivitis and
maculopapular rash. The largest public health risk from ZIKV is its association with neurologi-
cal conditions such as Guillain-Barré syndrome and microcephaly which place substantial
strains on local communities and healthcare providers.
As is characteristic of flaviviruses, ZIKV possesses a linear single-stranded, positive-sense
RNA genome. The flavivirus genome has a single open reading frame that encodes all struc-
tural and non-structural proteins flanked by 5´ and 3´ untranslated regions (UTRs) [21]. Phy-
logenetic analysis of partial ZIKV sequence data revealed isolates may be categorised into
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African and Asian lineages, of which the African lineage is further subdivided into Nigerian
and MR766 prototype strain clades [22, 23]. Recently obtained sequences from the current epi-
demic are of Asian lineage and are most closely related to strains from the French Polynesian
outbreak in 2013 [5, 6, 24]. However, there are currently few full-length complete sequences
that include the genome termini. One of these is from the Americas and was derived from a
microcephaly case [10]. Nonetheless, such information is important given the relevance of the
genome termini and non-coding regions in virus translation, replication and pathogenesis. The
5’ and 3’ non-translated regions of flavivirus genomes have been shown to demonstrate con-
served secondary structures, cyclization elements, and are important for binding to several
host proteins in addition to proteins involved in viral replication complexes [25, 26]. Further-
more, the 3’UTR encodes subgenomic flavivirus RNA (sfRNA) which is produced by the
incomplete degradation of viral RNA by a cellular 5’-3’ exoribonuclease [27, 28]. These mole-
cules have been shown to be more than a by-product and are involved in viral interference with
innate immune responses in both vertebrates and invertebrates through antagonizing type I
interferon and RNA interference responses respectively [29–36].
Herein we present the complete genome sequence of a ZIKV isolate derived from a patient
in Brazil with classical disease symptoms. This will be important for future studies and the
development of reagents, such as reverse genetics systems, for ZIKV. We also identified ZIKV-
derived sfRNA in infected cells and show that it functions as an antagonist of RIG-I mediated
induction of type I interferon, while a lesser effect on MDA-5 mediated induction was
observed.The production of sfRNA in ZIKV infectionmay be an important contributor to
associated pathogenesis.
Materials and Methods
Ethics statement
This study was approved by the Brazilian Ethics Committee, Process number: IMIP Human
Ethics Research Committee Approval number 4232, PlatBr580.333 and 44462915.8.2004.5190.
The virus reported here, ZIKV/H. sapiens/Brazil/PE243/2015 (abbreviated to ZIKV PE243),
was isolated in Recife (Brazil) in 2015 from a patient (rash on face and limbs; arthralgia hands,
fist/wrist, ankle; edema on hands, fist/wrist; no neurological symptoms). All patients who
agreed to participate in this study were asked to sign an informed consent form.
Virus isolation from cell culture
ZIKV from positive serum samples was isolated at Fundação Oswaldo Cruz (FIOCRUZ),
Recife (Brazil) by amplification in C6/36 Ae. albopictus cells. then Vero cells, which are fre-
quently used for virus isolation and were obtained from collections at FIOCRUZ. Briefly, 50 μl
of positive serumwas incubated for 1 h at room temperature on monolayers of C6/36 cells.
The cells were then further incubated for 7 days. Following this, ZIKV infection was confirmed
by RT-PCR as described below.
Viral RNA extraction and RT-PCR
Viral RNA was extracted from serumof suspected acute DENV/ZIKV cases using the QIAmp
Viral RNA Mini kit (Qiagen) following the manufacturer’s instructions. RNA was extracted
from 140 μl of the sample and stored at -70°C prior to downstream applications. RT-PCR was
carried out using the QIAGEN OneStep RT-PCR kit in a final volume of 25 μl following previ-
ously established protocols and primers [22].
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Virus growth and titration by plaque assay
Vero E6 cells, a commonly used cell line for the growth of viruses [37] were infected with ZIKV
PE243 for the preparation of virus stocks which were collected upon detection of cytopathic
effect. ZIKV PE243 infected cells tested positive with mouse anti-ZIKV serum (provided by G.
Fall and A. A. Sall, Institut Pasteur de Dakar, Senegal) as well as with commercially obtained
ZIKV E protein-specific antibodies by western blotting and immunofluorescence (S1 File). For
titration, Vero E6 cells were infected with serial dilutions of virus and incubated under an over-
lay consisting of DMEM supplemented with 2% FCS and 0.6% Avicel (FMC BioPolymer) at
37°C for 5–7 days. Cell monolayers were fixed with 4% formaldehyde. Following fixation, cell
monolayers were stained with Giemsa to visualize plaques. Plaque assays for plaque size com-
parisons were also performed using A549 and A549/BVDV-Npro cell lines (provided by R. E.
Randall, University of St Andrews, UK) [37–39].
Detection of ZIKV PE243 sfRNA by northern blot
Denaturated total RNA (3.5 μg per sample; isolated fromVero E6 cells infectedwith ZIKV
PE243 at an multiplicity of infection [MOI] of 1 by Trizol followed by Direct-zol RNA purifica-
tion) was separated on a denaturating formaldehyde agarose gel (1.5% agarose, 1x MOPS buffer
[Fisher Scientific], 12.3 M formaldehyde) in 1xMOPS running buffer. RNA was transferred onto
a Hybond-N+membrane (GEHealthcare Life Sciences) via capillary transfer action using 10x
SSC (1.5 MNaCl, 150 mM trisodiumcitrate). RNA was crosslinked to the membrane by UV
(120 mJ/cm2). Following transfer, the membrane was prehybridized for 2 h in PerfectHyb Plus
Hybridization buffer (Sigma-Aldrich) at 65°C. Specific oligonucleotides for the sfRNA region of
the ZIKV PE243 3’UTR (forward: AGCTGGGAAACCAAGCCTAT, reverse: GTGGTGGAAAC
TCATGGAGTCT) were used to amplify a fragment by PCR with KOD polymerase (Merck
Millipore). Following this 250 ng of the PCR product was end-labelledwith 32P using T4 Polynu-
cleotide Kinase (NEB) and [γ-32P]Adenosine 5’-triphosphate (PerkinElmer) to produce a probe.
The probe was denatured for 5 min at 95°C and added to prehybridization mixture which was
incubated on the membrane overnight at 65°C. The membrane was then washed twice for 15
min at 65°C with each of the following three buffers: 2x SSC and 0.5% SDS, 2x SSC and 0.2%
SDS, 0.2x SSC and 0.1% SDS. RNA species were detected by phosphorimaging.
Cloning of ZIKV 3’UTR
The Gateway cloning system was used for cloning the 3’UTR of ZIKV, potentially containing the
sfRNA sequence, fused to hepatitis delta virus ribozyme (HDVr) into pDEST40 (mammalian
expression vector [Invitrogen]). The 3’UTR of ZIKV PE243 was amplified by PCR using 1 μl of
the 3' end RACE reaction as a template. Subsequently, fusion PCR was performedusing the
primers described in Table 1. The resulting fragment was inserted into the pDONR207 using BP
Clonase II kit (Invitrogen) and sequenced using the pDONR201 forward primer. LR Clonase II
kit (Invitrogen) was used for the recombination of pDONR207-ZIKVPE243-3’UTR (entry vec-
tor) and the empty pDEST40 resulting in pDEST40-ZIKV PE243-3’UTR. The sequence of
pDEST40-ZIKV PE243-3’UTRwas validated using the T7 promoter forward primer. Similar
cloning strategies have been used for other flavivirus 3’UTRs containing sfRNA [29, 30].
Interferon assays
In vitro type I interferon assays were performed using the human A549 cell line [37] to analyze
the activity of the IFN-β promoter in the presence of plasmids expressing flavivirus 3’UTRs
containing the sfRNA sequence. A549 cells were grown in DMEM (supplemented with 10%
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FBS, 1000 units/ml penicillin and 1 mg/ml streptomycin) at 37°C with 5% CO2. Briefly, 24 h
prior to transfection, A549 cells were seeded in 24 well plates at a density of 1.2x105 cells/well
to reach 70% confluency the following day. Cells were first co-transfectedwith 400 ng p125Luc
IFN-β promoter reporter vector expressing Firefly luciferase [40], 2 ng pRL-CMV (internal
control, expressing Renilla luciferase), and 500 ng of either pDEST40 expressing DENV [29] or
ZIKV 3’UTRs (constructs described in this study) or a MBP-HDVr (maltose-binding protein-
HDVr) control using Opti-MEM and Lipofectamine2000 (Invitrogen) according to the manu-
facturer’s protocol. Following a further 24 h incubation, type I interferon induction was stimu-
lated by transfecting the cells a second time with either 10 μg/well poly I:C, 50 ng Vero cell
produced EMCV RNA or 50 ng Neo1-99 IVT-RNA (universal, MDA-5 specific and RIG-I spe-
cific type I interferon agonists respectively) [41, 42]. Cells were lysed in 1x passive lysis buffer
(Promega) 24 h after the second transfection and Firefly and Renilla luciferase activities deter-
mined using a Dual-Luciferase reporter assay kit (Promega) in a GloMax luminometer.
Virus infection for RNA sequencing
Vero E6 cells were infected with ZIKV at an MOI of 0.001 in triplicate. At 48 h post infection
(p.i.), cell culture supernatant was harvested and clarified by low speed centrifugation. Follow-
ing clarification, 6 ml of infected cell supernatant was concentrated to 250 μl using an Ultra-15
Centrifugal Filter Units with 100 kDamolecular weight cut-off (Amicon). Concentrated super-
natant was then added to Direct-zol solution and RNA extracted using a Direct-zol RNA mini
kit (Zymogen) according to the manufacturer’s instructions. PurifiedRNA was then stored at
-80°C for further downstream processing.
RACE analysis of viral genome termini
Sequencing of the 5’ and 3’ termini of the viral genome was performed using a 5’/3’ RACE kit
(Roche) following the manufacturer’s protocol. All primers used are described in Table 2. To
Table 1. Primers used for cloning of ZIKV 3’UTR containing sfRNA.
Primer Use Sequence (5’-3’)
ZIKV-3’UTR-FW ZIKV 3’UTR amplification GCACCAATCTTAATGTTGTCAGG
ZIKV-3’UTR-RV AGACCCATGGATTTCCCC
ZIKV-3’UTR-attB-FW amplification of attB-ZIKV 3’UTR-HDVr
fragment
GGGGACAAGTTTGTACAAAAAAGCAGGCTTCGCACCAATCTTAATGTTGTC
ZIKV-
3’UTR-HDVR-RV
CATGCCGACCCAGACCCATGGATTTCCCCA
HDVR-ZIKV-
3’UTR-FW
amplification of ZIKV 3’UTR-HDVr-attB
fragment
GAAATCCATGGGTCTGGGTCGGCATGGCATCTC
HDVR-attB-RV (E10) GGGGACCACTTTGTACAAGAAAGCTGGGTTTTCCGATAGAGAATCGAGAGAAAA
pDONR201 forward sequencing (pDONR207) TCGCGTTAACGCTAGCATGGATCTC
T7 promoter (F) sequencing (pDEST40) TAATACGACTCACTATAGGG
doi:10.1371/journal.pntd.0005048.t001
Table 2. Primers sequences used for 5’/3’ RACE of ZIKV viral termini.
Primer Use Sequence (5’-3’)
SP1 cDNA synthesis CTCATGGTGGCATCACACATGTGTCCAAGATCC
5’ PCR PCR amplificiation TGCACTCCCACGTCTAG
3’ PCR PCR amplification TGGCCAATGCCATTTGTTCATCTGTGC
5’ SEQ Sequencing CATCTATTGATGAGACCCAGTGATGGC
3’ SEQ Sequencing GAAGACTTGTGGTGTGGATCTCTCATAGGGCACAG
3’ SEQ2 Sequencing GCCTGAACTGGAGATCAGCTGTGGATC
doi:10.1371/journal.pntd.0005048.t002
Genome Sequence of Zika Virus from Recife, Brazil
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0005048 October 5, 2016 5 / 20
obtain the 5’ end sequence of the ZIKV genome 5’ RACE was performed. Briefly, 1 μg total
RNA was extracted from ZIKV-infected Vero E6 cells using a Direct-zol RNA mini kit and
reverse transcribed using the ZIKV specific primer, SP1. The synthesized cDNA was purified
using the illustra GFX PCR DNA and Gel Band Purification kit (GE Healthcare) according to
the manufacturer’s instructions. This was prior to polyadenylation at the 3’ end and amplifica-
tion using the PCR anchor primer and a ZIKV specific primer (5’ PCR). 3’ RACE was carried
out to obtain the 3’ end sequence using 1 μg total RNA extracted from ZIKV infectedVero
cells which was polyadenylated at the 3’ end using Poly(A) polymerase (New England Biolabs)
following the manufacturer’s guidelines. cDNA synthesis was performed by reverse transcrib-
ing the RNA using the oligo (dT) anchor primer. Amplification of the cDNA was achieved by
using the PCR anchor primer and a ZIKV specific primer (3’ PCR). The PCR cycling condi-
tions were 95°C for 2 min then 35 cycles of 95°C 20 sec, 56°C (5’ RACE) or 68°C (3’ RACE) for
10 sec, 70°C for 15 sec and 70°C for 7 min.
cDNA synthesis and NGS library preparation
A volume of 25 μl of cell culture supernatant was treated with RNase-free DNase I (Ambion),
purifiedwith RNAClean XP magnetic beads (BeckmanCoulter) and eluted in 11 μl of water.
In parallel, an equivalent sample was concentrated from 25 to 11 μl using magnetic beads as
indicated above, in the absence of DNase I treatment. In addition, 45 μl of extracted total cellu-
lar nucleic acid was treated with RNase-free DNase I and purified as above. Half of the volume
was further depleted of ribosomal RNA (RiboZeroGold) according to the manufacturer's
protocol.
All samples were reverse-transcribedusing Superscript III (Invitrogen) followed by dsDNA
synthesis with NEB Next(r) mRNA Second Strand Synthesis Module (New England Biolabs).
Libraries were prepared using a KAPA DNA Library Preparation Kit (KAPA Biosystems), uti-
lizing a modifiedprotocol that includes ligation of the NEBnext adapter for Illumina (New
England Biolabs), followed by indexing with TruGrade oligonucleotides (Integrated DNA
Technologies) to eliminate tag crossover. Resulting libraries were quantified using a Qubit 3.0
fluorometer (Invitrogen) and their size determined using a 2200 TapeStation (Agilent). Librar-
ies were pooled in equimolar concentrations.
Sequencing analysis
Samples from different passages were sequenced on a NextSeq500 platform (Ilumina). This
obtained 24,275,098 read pairs (2x150bp) and 88.8% of reads had a quality score of>Q30.
Bioinformatic analysis
Reads were first checked for quality using FASTQC (http://www.bioinformatics.babraham.ac.
uk/projects/fastqc/) and trimmed for adapter sequences and quality filtered using trim_galore
(http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/). These were subsequently
mapped to the ZIKV complete genome KU321639 using two different aligners: Tanoti (http://
www.bioinformatics.cvr.ac.uk/tanoti.php) and Bowtie2 [43]. The assembly was parsed using
customized scripts to determine the frequency of nucleotides at each site and reconstruct a con-
sensus with nucleotides above 50%. The complete genome was extended at the 5’ and 3’UTRs
by extracting additional reads that overlapped with the terminal ends of the consensus
sequence. The sequence of the ZIKV PE243 genome has been deposited in GenBankwith the
accession number KX197192.
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Phylogenetic and sequence analysis
Phylogenetic and comparison analyses were carried out using full coding sequence alignments
that were generated using MUSCLE [44] within the program suite Geneious (version 7.1.8:
http://www.geneious.com) [45]. These alignments were created using our ZIKV PE243
sequence in addition to publicly available coding sequences on GenBank. All Asian and African
lineage ZIKV sequences used for the analysis are described in S1 Table. A single African
sequence (MR-766, accession NC_012532) was used as an outgroup. Before generating phylog-
enies, the data set was analyzed for the presence of recombination. The Recombination Detec-
tion Program version 4 (RDP4) [46] software was utilized, specifically the programs RDP,
Chimaera, BootScan, 3Seq, GENECONV, MacChi & SiScan. Phylogenies were generated with
both maximum likelihood and Bayesian inference methods using the software packages
PhyML [47] and MrBayes (version 3.2.6) [48] respectively. Support for the maximum likeli-
hood tree topologywas generated by 1,000 non-parametric bootstrap replicates. For the Bayes-
ian analysis one MCMC run of four heated chains of length 1,000,000 was utilized to ensure an
effective sample size of at least 200. The run was sampled every 200th generation and the first
10% of samples were discarded as burn-in. The generalized time reversible (GTR) substitution
model with gamma distribution (+G) was found to suit the data set best, as selected by both
jModel Test [49] and HyPhy [50] software packages. The topologies of both the Bayesian and
maximum likelihood trees were identical; here we present only the Bayesian tree.
Statistical analysis
All data were analysed using Prism 5 software (GraphPad) and presented as mean ± standard
error. Statistical significance for the comparison of means between groups was determined by a
two-way ANOVA; p values0.05 were considered significant.
Results and Discussion
Characterization of ZIKV/H. sapiens/Brazil/PE243/2015
At the time of writing, 62 ZIKV genomes are available on GenBank, of which 37 are published.
Of these only 11 showed both 5’ and 3’ complete UTRs (accessed 16th April 2016). A summary
of currently available strain information and accession numbers is presented in S1 Table. ZIKV
PE243 was isolated from a patient presenting with classical symptoms associated with ZIKV
infection and the complete viral genome sequence including the non-coding regions was deter-
mined. The UTRs are largely missing in many sequences from the Americas, with some excep-
tions including the Natal isolate derived from a case presenting with microcephaly [10]. Only
recently have more full-length ZIKV sequences been described [51, 52].
Our phylogenetic analysis uses the entire protein-coding region and the position of our iso-
late was supported by a posterior probability node support of 1. Recombination screening
prior to analysis also produced no signals. The sequence of ZIKV PE243 used for further analy-
sis (as deposited in GenBank) derives from virus that had been passaged five times in Vero E6
cells upon receipt by the Centre for Virus Research (Glasgow, UK) on a NextSeq500 (average
depth of coverage of 5637, range 52–13691). Three nucleotide substitutions were observed fol-
lowing the sequencing of this virus compared to a previous passage of the isolate (passage two)
that had been sequenced on a MiSeq platform (these earlier data did not generate complete
coverage; average depth of coverage of 1158, range 2–2944). The mutations observed are as fol-
lows: site 2784, 1149 out of 1159 reads had A in the MiSeq run (after two passages) and 3508
out of 3910 reads had G in the NextSeq run after a further three passages. The mutation
A2784G corresponds to the amino acid substitution R893G in NS1. The mutations observed in
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NS3 (U5231C: 1727/1730 Ts in passage two versus 7031/7623 Cs in passage five) and NS4B
(A7637G: 1835/1846 As in passage two versus 9578/10587 Gs in passage five) were synony-
mous. These three substitutions represent mutations obtained during adaptation in cell culture
between passage two and passage five. The mutations A2784G and U5231C are unique to
ZIKV PE243 and are not found in any other strains published to date. Phylogenetic analysis
based on the entire protein coding region grouped the ZIKV PE243 isolate with another 2015
Brazilian isolate (KU321639, ‘ZikaSPH2015’) with 100% posterior support (Fig 1). As expected,
our isolate clusters with other strains from the Americas which belong to the Asian lineage that
is attributed to the epidemic in French Polynesia in 2013 (Fig 1). Previous findings have shown
that American isolates are genetically very comparable, with approximately 99% homology at
the nucleotide level, and there is less than 12% diversity between strains from both African and
Asian lineages [24, 53]. Our data are in agreement with this as ZIKV PE243 demonstrates a
strong degree of conservation at amino acid level (98.3% pairwise identity) with sequences
from 62 isolates (Fig 2). ZIKV PE243 shares the greatest level of similarity with the Brazilian
isolate ZikaSPH2015 (99.9% at the nucleotide level and 99.97% at amino acid level) [54] and
the passage two isolate matched the coding region precisely. There is no obvious virological
explanation, based upon our sequence analysis, for the increased occurrence of neurological
disease cases associated with the outbreak in Brazil. This is in accordance with other findings
which have similarly suggested that there are no specificmutations in the viral genome associ-
ated with severe cases [54]. However, the role of mutations in ZIKV isolates needs to be
assessed by reverse genetics approaches to provide conclusive evidence.
We also successfully sequenced both the 5’ and 3’ non-coding regions (Figs 3 and 4). Of the
62 sequences publicly available (as of 16th April 2016), 48 sequences with 5’UTR information
are shown in the consensus alignment (Fig 3). ZIKV strains ZIKV/Homo sapiens/NGA/ibH-
30656_SM21V1-V3/1968 and ZIKV/Macaca mulatta/UGA/MR-766_SM150-V8/1947 contain
large insertions and were subsequently excluded from 5’UTR analysis. The 5’UTR of ZIKV
PE243 shares 100% sequence identity with the consensus sequence (the most common bases
between all sequences analyzed) and overall very fewmismatches are detected across all 48
sequences studied. The 5’UTR is largely conserved between isolates of the same lineage and is
approximately 107 nucleotides long in isolates from the Asian lineage, similar to the length
shown for MR766 strain and other African lineage viruses. There was strong similarity between
ZIKV PE243 and Natal RGN, a Brazilian isolate associated with microcephaly [10], while
ZIKV PE243 was associated with classical symptoms. Similarly, there are fewmismatches
between known 3’UTRs (Fig 4). These non-coding regions are expected to be approximately
428 nucleotides in length as seen for many Asian and African isolates.
ZIKV PE243 produces interferon antagonist sfRNA
The host interferon response is known to be essential for fighting viral infections and prevent-
ing virus replication, including mosquito-borne flaviviruses [55–58]. This has been specifically
illustrated for ZIKV as in vivo pathogenesis studies require murine models lacking type I inter-
feron [59], while type III interferon has been shown to have a protective role against ZIKV
infection in human placental cells [60]. Furthermore, ZIKVNS5 has recently been described as
a type I IFN signaling antagonist that targets STAT2 [61]. Indeed, ZIKV PE243 was also sus-
ceptible to type I interferon responses and producedmuch larger plaque sizes in the type I
interferon incompetent A549/BVDV-Npro cell line than in A549 cells (S1 Fig).
However, viruses also employ mechanisms that allow them to counteract the host’s inter-
feron responses in order to replicate efficiently. Mosquito- and tick-borne flaviviruses express
sfRNA derived from the 3’ terminus, which is resistant to RNase (XRN1)-mediated virus
Genome Sequence of Zika Virus from Recife, Brazil
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genome degradation due to RNA stem loop structures and pseudoknots in this region [27, 28].
Interestingly, sfRNA has been implicated in pathogenesis, immune evasion and inhibition of
small RNA-based responses [29–34]. Thus, a similar subgenomic RNA produced during ZIKV
infection could be important in the development of disease and virus-host interactions. Based
on our sequence data and comparisons to other mosquito-borne flavivirus 3’UTRs, we pre-
dicted the structure of ZIKV PE243 sfRNA (Fig 5). Secondary structures, specific for flavivirus
3’UTRs, were detected in the 3’UTR of ZIKV PE243 by Clustal alignments of the 3’UTR of
ZIKV PE243, yellow fever virus (X03700, K02749), DENV2 (M19197), Kunjin virus
(AY274504), Japanese encephalitis virus (AF014161) and Murray Valley encephalitis virus
Fig 1. Bayesian maximum clade credibility tree generated from coding sequence data. Bayesian
posterior probabilities are given at nodes of importance. Isolates which have been implicated in particular
diseases are highlighted, as is the ZIKV PE243 isolate we have sequenced. GenBank accession numbers of
all sequences used are given in S1 Table. EC_2007 refers to the epidemic consensus sequence generated
from the Yap Island outbreak in 2007 (EU545988).
doi:10.1371/journal.pntd.0005048.g001
Fig 2. Comparison of African and Asian lineage ZIKV protein coding regions. The mean pairwise identity of all pairs at a given position is indicated
by the identity bar; light blue denotes 100% pairwise identity, dark blue highlights positions possessing less than 100% pairwise identity. Positions and
quantity of amino acid substitutions are indicated by black bands within grey sequence bars. Sequences 1–37, highlighted yellow, correspond to the
outbreak originating in 2015 in South America. Microcephaly, adult mortality and ZIKV PE243 associated sequences are highlighted as previously
described in Fig 1.
doi:10.1371/journal.pntd.0005048.g002
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(AF161266) in combination with Mfold. Putative pseudoknot interactions were determined by
hand. Further analysis was also carried out to compare the 3’UTR sequences betweenZIKV
PE243 and 3 African strain isolates (twoMR766 isolates [AY632535, KX377335] and another
African isolate [KU955592]). Our comparisons suggest that the sequence differences between
these Asian and African isolates do not, or are unlikely to, affect the predicted sfRNA structure
(S2 Fig, S3 Fig and S2 Table).
Our sequence data for ZIKV PE243 and predictive analysis suggested that the ZIKV sfRNA
molecule begins 15 nt after the stop codon of the open reading frame and is 413 nt in length.
This was further confirmed by northern blot analysis, which indicates a band at the anticipated
size present only in ZIKV PE243 infected cell lysate (Fig 6). It is important to determine
whether this molecule is involved in inhibition of type I IFN production as previously
described for other flavivirus sfRNAs [27]. To test this hypothesis, cells were co-transfected
Fig 3. Comparison of the 5’UTR nucleotide sequences of Asian and African ZIKV isolates. The mean pairwise identity of all pairs
at a given position is indicated by the identity bar; lilac is indicative of 100% pairwise identity, dark purple highlights positions
possessing <100% pairwise identity. Positions and quantity of single nucleotide polymorphisms (SNPs) are represented as black bands
within grey sequence bars. Sequences 1–32, highlighted orange, correspond to the outbreak originating in 2015 in Brazil.
Microcephaly, adult mortality and ZIKV PE243 associated sequences are highlighted as previously described in Fig 1.
doi:10.1371/journal.pntd.0005048.g003
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with a reporter plasmid (p125Luc) expressing Firefly luciferase under the control of the IFN-β
promoter as well as plasmids expressing either ZIKV or DENV 3’UTRs which contain the
sfRNA sequences. The IFN-β promoter was stimulated by treating with poly I:C (Fig 7).
As demonstrated in Fig 7, ZIKV PE243 sfRNA reduced activation of the IFN-β promoter to
the same level as DENV sfRNA compared to MBP-HDVr control. This shows that ZIKV
sfRNA functions in a similar manner to other flavivirus sfRNA molecules and interacts with
important innate immune responses that may impact on virus replication and thus the severity
of the clinical outcome.
To further understand the mechanism of action ZIKV sfRNA molecules use to antagonize
the interferon response, the above assay was repeated this time using specific inducers of type I
interferon induction components, RIG-I and MDA-5 [41, 42]. Receptors such as RIG-I and
MDA-5 signal for the induction of IFN-α/β production through the detection of viral nucleic
acid [62, 63]. As shown in Fig 8, stimulation of RIG-I (Fig 8A) results in a significant decrease
in IFN-β promoter activity in the presence of both DENV and ZIKV sfRNAs compared to the
control. In contrast MDA-5 (Fig 8B) stimulation did not alter the activity of the IFN-β pro-
moter in the presence of DENV sfRNA, although a weak but significant decrease was observed
Fig 4. Comparison of the 3’UTR nucleotide sequences of Asian and African ZIKV isolates. The mean pairwise identity of all pairs at a
given position is indicated by the identity bar; light green is indicative of 100% pairwise identity, dark green highlights positions possessing less
than 100% pairwise identity. Sequences 1–32, highlighted orange, correspond to the outbreak originating in 2015 in Brazil. Microcephaly,
adult mortality and ZIKV PE243 associated sequences are highlighted as previously described in Fig 1.
doi:10.1371/journal.pntd.0005048.g004
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in ZIKV sfRNA expressing cells. These data suggest that both ZIKV and DENV antagonize
RIG-I mediated type I interferon induction. Our data is consistent with previous findings for
DENV sfRNA which found that DENV sfRNA binds TRIM25 interfering with its deubiquityla-
tion, consequently hindering RIG-I mediated interferon induction [34]. Only ZIKV sfRNA
antagonizedMDA-5 activity in this assay, although the biological significance of this is yet to
be clarified.
Over the past 40 years there has be an upsurge in the number of cases of important arbovi-
rus infections such as DENV, CHIKV andWest Nile virus (WNV), and ZIKV is now another
emerging arbovirus of significant clinical importance. The factors involved in the emergence of
ZIKV from a rarely detected pathogen to a major epidemic are yet to be determined and could
include genetic adaptation, environmental influences, interactions with other pathogens within
infected individuals and changes in population dynamics of the virus. To date, the northeast
region of Brazil has reported a significant increase in cases of microcephaly and it is important
to understand the determinants that lead to this clinical outcome. It has been suggested that
alterations in codon usage in the NS1 gene may have facilitated an adaptation towards
improved fitness for human infections in the Asian lineage over the African [64]. These
changes, combined with the geographical ranges throughout the Americas of its vector popula-
tion, may have contributed to its accelerated spread. More work is required to analyze these
possibilities, and reverse genetics systems in particularwill be key to studying mutations and
genetic diversity within viral populations. The 5’ and 3’UTRs are important for virus replica-
tion and are therefore required for the development of such reverse genetic systems [65] that
may be used in vaccine development or to advance knowledge of virus-host interactions. In
Fig 5. The predicted structure of ZIKV PE243 3’UTR. 5’-3’ of the ZIKV PE243 3’UTR sequence, left to right. The
arrow indicates the predicted start of sfRNA. Nucleotides are indicated either counted from the 3’ (indicated as
negative numbers) or from the start of the 3’UTR (positive number in brackets). SL, stem loop structure; DBL,
dumbbell structure; 3’SL; 3’ end stem loop structure. The dotted line represents the predicted pseudoknot.
doi:10.1371/journal.pntd.0005048.g005
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order to understand not only ZIKV evolution and pathogenesis but also to support the devel-
opment of virus-based tools, it is imperative to generate full virus genome sequences from
ZIKV isolates in the Americas and elsewhere associated with classical and non-classical symp-
toms. Although new scientific information about ZIKV is published on a near daily basis,
many avenues of research are yet to be fully explored in order to understand the clinical mani-
festations surrounding this outbreak. Characterization of the full sequence of ZIKV PE243
from a patient with symptoms classically associated with infection adds to our understanding
of the virus genetics.We have also shown that ZIKV, like other pathogenic flaviviruses infect-
ing humans, encodes sfRNA which inhibits type I interferon induction and thus is likely to
Fig 6. sfRNA production in ZIKV PE243 infection. Top panel: Vero E6 cells were infected with ZIKV
isolate PE243 and sfRNA detected by northern blot. Total RNA isolated from Vero E6 cells infected with
ZIKV PE243 was separated on a denaturing agarose gel and transferred to a nylon membrane as described
in Materials and methods. Radiolabeled DNA probe complementary to 3’UTR was used to detect genomic
RNA and sfRNA. Bottom panel: assessed amounts of 18S ribosomal RNAs (fluorescently labelled with
ethidium bromide) prior to transfer.
doi:10.1371/journal.pntd.0005048.g006
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Fig 7. Activation of the IFN-β promoter by poly I:C in cells over expressing ZIKV sfRNA. A549 cells were co-transfected with
either pDEST-DENV-3’UTR, pDEST-ZIKV PE243-3‘UTR or pDEST40-MBP (sfRNA over-expression plasmids and MBP-HDVr control,
respectively) and p125Luc IFN-β promoter reporter (expressing Firefly luciferase) along with pRL-CMV (internal control, expressing
Renilla luciferase). The IFN-β promoter was stimulated by transfecting poly I:C 24 h after the primary transfection. The relative
luciferase activity (Firefly/Renilla) was analyzed at 24 h following the second transfection. The mean with standard error is shown for
three independent experiments performed in triplicate; values of independent experiments were used for analysis. The data were
normalized to cells transfected with pDEST40-MBP without any poly I:C treatment. Asterisk (*) indicates significance (2-way ANOVA,
p<0.05).
doi:10.1371/journal.pntd.0005048.g007
Fig 8. Activation of the IFN-β promoter by RIG-I or MDA-5 agonists in cells over-expressing ZIKV sfRNA. A549 cells were co-transfected
as described with either pDEST-DENV-3’UTR, pDEST-ZIKV PE243-3‘UTR or pDEST40-MBP and p125Luc IFN-β promoter reporter along with
pRL-CMV. The IFN-β promoter was stimulated by transfecting either RIG-I agonist (Neo1-99 IVT-RNA) (A) or MDA-5 agonist (Vero cell produced
EMCV RNA) (B) 24 h after the primary transfection. The relative luciferase activity (Firefly/Renilla) was analyzed at 24 h following the second
transfection. The mean with standard error is shown for three independent experiments performed in duplicate; values of independent
experiments were used for analysis. The data were normalized to cells transfected with pDEST40-MBP without any agonist treatment. Asterisk (*)
indicates significance (2-way ANOVA, p<0.05).
doi:10.1371/journal.pntd.0005048.g008
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contribute to viral pathogenesis. Our interferon induction assays suggest that ZIKV sfRNA
may have broader antagonist activity compared to DENV sfRNA, which could contribute to
disease outcome and requires further investigation. The data shown here give important
insights into virus-host interactions that will help guide future research efforts in this field.
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